AHRQ Finds Insufficient Evidence for Gene Tests for DVT | GenomeWeb

NEW YORK (GenomeWeb News) – A new report released yesterday by the Agency for Healthcare Research and Quality found insufficient evidence that genetic tests for two gene mutations help prevent deep-vein thrombosis, a condition that includes blood clots in the leg and pelvis and can lead to death.

Researchers at the Johns Hopkins Evidence-based Practice Center were unable to find any studies that directly addressed the effect of genetic tests for two mutations, including Factor V Leiden and prothrombin G20210A mutations, AHRQ said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.